Skip Navigation


Hum. Reprod. Advance Access originally published online on August 11, 2005
Human Reproduction 2005 20(12):3284-3292; doi:10.1093/humrep/dei244
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
20/12/3284    most recent
dei244v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Strandell, A.
Right arrow Articles by Eckerlund, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strandell, A.
Right arrow Articles by Eckerlund, I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Cost—effectiveness analysis of salpingectomy prior to IVF, based on a randomized controlled trial

Annika Strandell1,4, Anette Lindhard2 and Ingemar Eckerlund3

1 Reproductive Medicine, Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Göteborg, Sweden, 2 Fertility Unit, Department of Gynecology and Obstetrics, Roskilde Hospital, Copenhagen University, Roskilde, Denmark and 3 Swedish Council on Technology Assessment in Health Care, Stockholm, Sweden

4 To whom correspondence should be addressed. E-mail: annika.strandell{at}medfak.gu.se

BACKGROUND: In patients with ultrasound-visible hydrosalpinges, salpingectomy prior to IVF increases the chance of a live birth. This study compared the cost-effectiveness of this strategy (intervention) with that of optional salpingectomy after a failed cycle (control). METHODS: Data from a Scandinavian randomized controlled trial were used to calculate the individual number of treatments and their outcomes. Only patients with ultrasound-visible hydrosalpinges were considered in the main analysis, and a maximum of three fresh cycles were included. The costs for surgical procedures, IVF treatment, medication, complications, management of pregnancy and delivery as well as of early pregnancy losses were calculated from standardized hospital charges. RESULTS: Among the 51 patients in the intervention group, the live birth rate was 60.8% compared with 40.9% in 44 controls. The average cost per patient was {euro}13 943 and {euro}12 091, respectively. Thus, the average cost per live birth was {euro}22 823 in the intervention group and {euro}29 517 in the control group. The incremental cost-effectiveness ratio for adopting the intervention strategy was estimated at {euro}9306. CONCLUSIONS: The incremental cost to achieve the higher birth rate of the intervention strategy seems reasonable.

Key words: cost-effectiveness/hydrosalpinx/incremental cost-effectiveness ratio/in vitro fertilization/salpingectomy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 ESHRE MonogrHome page
R. Campo and C. R. Molinas
Modern endoscopic-based exploration of the female reproductive tract: a model for developing countries?
ESHRE Monogr, July 1, 2008; 2008(1): 54 - 59.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.